0001209191-23-015861.txt : 20230303 0001209191-23-015861.hdr.sgml : 20230303 20230303175247 ACCESSION NUMBER: 0001209191-23-015861 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeSimone Jill CENTRAL INDEX KEY: 0001930479 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39743 FILM NUMBER: 23706303 MAIL ADDRESS: STREET 1: C/O PRAXIS PRECISION MEDICINES, INC. STREET 2: 99 HIGH STREET, 30TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kinnate Biopharma Inc. CENTRAL INDEX KEY: 0001797768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824566526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582994699 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-03-01 1 0001797768 Kinnate Biopharma Inc. KNTE 0001930479 DeSimone Jill 103 MONTGOMERY STREET, SUITE 150 THE PRESIDIO OF SAN FRANCISCO SAN FRANCISCO CA 94129 1 0 0 0 /s/ Mark A. Meltz, attorney-in-fact 2023-03-03 EX-24 2 attachment1.htm EX-24 DOCUMENT

             Exhibit 24
		LIMITED POWER OF ATTORNEY FOR
             	SECTION 16 REPORTING OBLIGATIONS
             	The undersigned, as a Section 16 reporting person of Kinnate
Biopharma Inc. (the "Company"), hereby constitutes and appoints Nima Farzan,
Mark Meltz, James Reilly, and Lance Brady as the true and lawful
attorneys-in-fact of the undersigned to:
             1.	complete and execute Forms 3, 4 and 5 and other forms and all
amendments thereto as such attorneys-in-fact shall in their discretion determine
to be required or advisable pursuant to Section 16 of the Securities Exchange
Act of 1934 (as amended) and the rules and regulations promulgated thereunder,
or any successor laws and regulations, as a consequence of the ownership,
acquisition or disposition of securities of the Company by the undersigned; and
             2.	do all acts necessary in order to file such forms with the
Securities and Exchange Commission, any securities exchange or national
association, the Company and such other person or agency as the
attorneys-in-fact shall deem appropriate.
             The undersigned hereby ratifies and confirms all that said
attorneys in-fact and agent shall do or cause to be done by virtue hereof.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming, nor is the
Company assuming, any of the responsibilities of the undersigned to comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).
             This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the holdings of and transactions in securities issued by the Company of the
undersigned, unless earlier revoked by the undersigned in a signed writing
delivered to the Company and the foregoing attorneys-in-fact.
             IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of the date set forth below.

             By: /s/ Jill DeSimone
             Name: Jill DeSimone
             Date: February 6, 2023